Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Diabetes Mellitus, Non-Insulin-Dependent
0.700 Biomarker disease GENOMICS_ENGLAND
Diabetes Mellitus, Non-Insulin-Dependent
0.700 CausalMutation disease CLINVAR
Diabetes Mellitus, Non-Insulin-Dependent
0.700 Biomarker disease HPO
Diabetes Mellitus, Non-Insulin-Dependent
0.700 Biomarker disease GENOMICS_ENGLAND
Diabetes Mellitus, Non-Insulin-Dependent
0.700 Biomarker disease GENOMICS_ENGLAND
Diabetes Mellitus, Non-Insulin-Dependent
0.700 GeneticVariation disease CLINVAR
Diabetes Mellitus, Non-Insulin-Dependent
0.700 GeneticVariation disease BEFREE There was no evidence for linkage between these markers and NIDDM, suggesting that genetic variation in the BIR and SUR genes does not play a major role in susceptibility to NIDDM in Japanese. 8549873 1996
Diabetes Mellitus, Non-Insulin-Dependent
0.700 GeneticVariation disease BEFREE Sequence variants in the sulfonylurea receptor (SUR) gene are associated with NIDDM in Caucasians. 8635661 1996
Diabetes Mellitus, Non-Insulin-Dependent
0.700 GeneticVariation disease BEFREE These results suggest that genetic variation in the SUR gene does not play a major role in susceptibility to NIDDM in the Mexican-American population. 8786023 1995
Diabetes Mellitus, Non-Insulin-Dependent
0.700 GeneticVariation disease BEFREE The results of these studies thus revealed that mutations in the coding region of Kir6.2 1) were not responsible for the previously noted association of the SUR1 variants with NIDDM (Inoue H et al., Diabetes 45:825-831, 1996) and 2) did not contribute to the impaired insulin secretion characteristic of NIDDM in Caucasian patients. 9032109 1997
Diabetes Mellitus, Non-Insulin-Dependent
0.700 GeneticVariation disease BEFREE Studies of genes involved in insulin secretion or insulin action have been successful to a certain extent by showing the implication of the IRS-1 gene, the Rad gene, the glucagon receptor gene, or the sulfonylurea receptor (SUR) gene (among others) in a low percentage of cases of NIDDM in particular populations. 9059762 1997
Diabetes Mellitus, Non-Insulin-Dependent
0.700 GeneticVariation disease BEFREE Through association and linkage studies, we have investigated the potential role of the SUR gene in families with NIDDM and in two independent sets of morbidly obese families. 9075812 1997
Diabetes Mellitus, Non-Insulin-Dependent
0.700 GeneticVariation disease BEFREE The possible role of SUR1 gene mutation(s) in the development of NIDDM remains controversial as both a positive association and negative linkage results have been reported. 9519757 1998
Diabetes Mellitus, Non-Insulin-Dependent
0.700 GeneticVariation disease BEFREE The aim of this study was to examine if genetic variability of the SUR1 gene was associated with NIDDM or altered pancreatic beta-cell function. 9568693 1998
Diabetes Mellitus, Non-Insulin-Dependent
0.700 Biomarker disease CTD_human Mutational analysis of all the 39 SUR1 exons, including intron-exon boundaries, in 63 NIDDM patients revealed two missense variants, five silent variants in the coding region, and four intron variants. 9568693 1998
Diabetes Mellitus, Non-Insulin-Dependent
0.700 GeneticVariation disease BEFREE To assess the association of polymorphisms at the sulphonylurea receptor (SUR1) gene with the development of Type 2 diabetes mellitus, 456 subjects, 236 with Type 2 diabetes and 220 non-diabetic controls, were analysed for variants at exon 7, exon 22 and intron 24 of the SUR1 gene by the polymerase chain reaction and restriction fragment length polymorphism. 9796882 1998
Diabetes Mellitus, Non-Insulin-Dependent
0.700 GeneticVariation disease BEFREE Since we have previously reported linkage between SUR1 and hyperglycemia, the present association between a SUR1 variant and hyperinsulinemia in normal individuals from a high diabetes risk ethnic group raises the possibility of primary insulin hypersecretion as an antecedent of type 2 diabetes in at least some individuals from this population. 9799081 1998
Diabetes Mellitus, Non-Insulin-Dependent
0.700 GeneticVariation disease BEFREE Based on estimated haplotype frequencies in different Caucasian populations we conclude that multiple haplotypes on the SUR1 gene seem to confer a risk for developing Type II diabetes in Caucasians. 10333056 1999
Diabetes Mellitus, Non-Insulin-Dependent
0.700 Biomarker disease BEFREE Mutations at nt -3 of the splice acceptor site of exon 16 and a silent mutation in exon 18 of the gene for the sulphonylurea receptor (SUR1) associate with Type II (non-insulin-dependent) diabetes mellitus in several independent populations. 10819247 2000
Diabetes Mellitus, Non-Insulin-Dependent
0.700 GeneticVariation disease BEFREE These results suggest that a functional variant that contributes to the risk of GDM and type 2 diabetes may locate close to the SUR1 gene. 10857971 2000
Diabetes Mellitus, Non-Insulin-Dependent
0.700 GeneticVariation disease BEFREE These data reinforce the hypothesis that insulin secretion defects in T2DM might be at least partially related to allelic variations in the SUR1 gene. 11030411 2000
Diabetes Mellitus, Non-Insulin-Dependent
0.700 GeneticVariation disease BEFREE Secondly, novel and previously described variants associated with Type 2 diabetes (SUR1 exon 16-3t, exon 18 T, and Kir6.2 E23K) were investigated in the UKPDS cohort. 11318841 2001
Diabetes Mellitus, Non-Insulin-Dependent
0.700 GeneticVariation disease BEFREE The SUR1 intron 16 -3t-->c polymorphism was associated with an increased susceptibility to NIDDM in this population study, and seems to modulate the sulfonylurea therapy efficiency on hypertriglyceridemia reduction. 11343328 2001
Diabetes Mellitus, Non-Insulin-Dependent
0.700 GeneticVariation disease BEFREE Previous reported non-functional variants of SUR1 associated with Type II diabetes mellitus still need to be accounted for. 11692183 2001
Diabetes Mellitus, Non-Insulin-Dependent
0.700 Biomarker disease BEFREE The aim of this review is to summarise and discuss the significant results of recent literature on the implication of K(ATP), and particularly of SUR1, in the genetic and pathopysiological mechanisms of T2DM. 11938023 2002